BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19584398)

  • 1. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
    Navarro F; Gutman D; Meire E; Cáceres M; Rigoutsos I; Bentwich Z; Lieberman J
    Blood; 2009 Sep; 114(10):2181-92. PubMed ID: 19584398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
    Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
    Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
    Lu J; Guo S; Ebert BL; Zhang H; Peng X; Bosco J; Pretz J; Schlanger R; Wang JY; Mak RH; Dombkowski DM; Preffer FI; Scadden DT; Golub TR
    Dev Cell; 2008 Jun; 14(6):843-53. PubMed ID: 18539114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells.
    Kamat V; Paluru P; Myint M; French DL; Gadue P; Diamond SL
    Stem Cells; 2014 May; 32(5):1337-46. PubMed ID: 24446170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
    Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
    Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α (PDGFRA) in erythropoiesis and megakaryocytopoiesis.
    Zhai PF; Wang F; Su R; Lin HS; Jiang CL; Yang GH; Yu J; Zhang JW
    J Biol Chem; 2014 Aug; 289(33):22600-22613. PubMed ID: 24982425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells.
    Yuan JY; Wang F; Yu J; Yang GH; Liu XL; Zhang JW
    J Cell Mol Med; 2009; 13(11-12):4551-9. PubMed ID: 19017354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development.
    Sigurjonsson OE; Gudmundsson KO; Haraldsdottir V; Rafnar T; Agnarsson BA; Gudmundsson S
    Stem Cells Dev; 2004 Apr; 13(2):183-91. PubMed ID: 15186734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells.
    Liu CC; Chou YL; Ch'ang LY
    J Biomed Sci; 2004; 11(1):104-16. PubMed ID: 14730214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.
    Bianchi E; Ruberti S; Rontauroli S; Guglielmelli P; Salati S; Rossi C; Zini R; Tagliafico E; Vannucchi AM; Manfredini R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
    Zarif MN; Soleimani M; Abolghasemi H; Amirizade N; Arefian E; Rahimian A
    Hematology; 2013 Mar; 18(2):93-100. PubMed ID: 23321646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-22 promotes megakaryocyte differentiation through repression of its target,
    Weiss CN; Ito K
    Blood Adv; 2019 Jan; 3(1):33-46. PubMed ID: 30617215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and functional interactions between mitotic kinases during polyploidization and megakaryocytic differentiation.
    Huang X; Ruan Q; Fang Y; Traganos F; Darzynkiewicz Z; Dai W
    Cell Cycle; 2004 Jul; 3(7):946-51. PubMed ID: 15190214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit.
    Li X; Zhang J; Gao L; McClellan S; Finan MA; Butler TW; Owen LB; Piazza GA; Xi Y
    Cell Death Differ; 2012 Mar; 19(3):378-86. PubMed ID: 21979467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
    Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
    Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
    Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein.
    Testa U; Grignani F; Hassan HJ; Rogaia D; Masciulli R; Gelmetti V; Guerriero R; Macioce G; Liberatore C; Barberi T; Mariani G; Pelicci PG; Peschle C
    Leukemia; 1998 Apr; 12(4):563-70. PubMed ID: 9557615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.